Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors (Q56944919)
article
Language:
Current Data About Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors
(P31) (Q13442814)

(P50) (Q51093170)
(P1932) John Ducas
(P1545) 5

(Q5387640)
(P1545) 18
(P1932) Eric J. Topol

(Q19281782)
(P1545) 2
(P1932) Robert M. Califf

(Q62496584)
(P1545) 4
(P1932) Stephen G. Ellis

(Q63038136)
(P1545) 1
(P1932) A. Michael Lincoff

(Q88161889)
(P1545) 8
(P1932) Eric A. Cohen

(Q112157008)
(P1545) 7
(P1932) Neal S. Kleiman

(Q114292215)
(P1545) 12
(P1932) James E. Tcheng

(Q114292216)
(P1545) 10
(P1932) Shelly K. Sapp

(P304) 319-327

(P407) (Q1860)

(P433) 5

(P478) 341

(P577) Thursday, July 29, 1999

(P1433) (Q582728)

(P1476) "Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors" (language: en)

(P2093) David J. Moliterno
(P1545) 3

Jeffrey H. Kramer
(P1545) 6

Joan E. Booth
(P1545) 9

Catherine F. Cabot
(P1545) 11

J. David Talley
(P1545) 13

Paul O. Caramori
(P1545) 14

Jeffrey R. Burton
(P1545) 15

Thomas A. Kelly
(P1545) 16

Tom B. Ivanc
(P1545) 17

other details
description article

External Links
(P356) 10.1056/NEJM199907293410503
(P698) 10423466